Signatera by Natera vs Foundation Medicine
Side-by-side comparison of cancer screening tests.
← Back to Cancer Screening
Test Performance
| Feature | Signatera by Natera | Foundation Medicine |
|---|---|---|
| Price | Variable | Variable |
| Cancers Detected | Patient-specific | 324 genes |
| Sensitivity | Varies by cancer | N/A |
| Specificity | PPV >98% | N/A |
| Sample Type | Blood draw | Tumor tissue or blood |
| FDA Status | CLIA LDT (CDx approved only for bladder cancer) | FDA approved (CDx) |